$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

[해외논문] Epigenetic Associations between lncRNA/circRNA and miRNA in Hepatocellular Carcinoma 원문보기

Cancers, v.12 no.9, 2020년, pp.2622 -   

Han, Tae-Su (Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon 34141, Korea) ,  Hur, Keun (tshan@kribb.re.kr) ,  Cho, Hyun-Soo (Department of Biochemistry and Cell Biology, School of Medicine, Kyungpook National University, Daegu 41944, Korea) ,  Ban, Hyun Seung (KeunHur@knu.ac.kr)

Abstract AI-Helper 아이콘AI-Helper

Simple SummaryNon-coding RNAs such as microRNAs, long non-coding RNAs, and circular RNAs contribute to the development and progression of hepatocellular carcinoma through epigenetic association. Long non-coding RNAs and circular RNAs act as competing endogenous RNAs that contain binding sites for mi...

Keyword

참고문헌 (139)

  1. 1. Siegel R.L. Miller K.D. Jemal A. Cancer statistics, 2020 CA Cancer J. Clin. 2020 70 7 30 10.3322/caac.21590 31912902 

  2. 2. Parikh S. Hyman D. Hepatocellular cancer: A guide for the internist Am. J. Med. 2007 120 194 202 10.1016/j.amjmed.2006.11.020 17349437 

  3. 3. Liu C.J. Kao J.H. Hepatitis B virus-related hepatocellular carcinoma: Epidemiology and pathogenic role of viral factors J. Chin. Med. Assoc. 2007 70 141 145 10.1016/S1726-4901(09)70346-6 17475593 

  4. 4. Turati F. Galeone C. Rota M. Pelucchi C. Negri E. Bagnardi V. Corrao G. Boffetta P. La Vecchia C. Alcohol and liver cancer: A systematic review and meta-analysis of prospective studies Ann. Oncol. 2014 25 1526 1535 10.1093/annonc/mdu020 24631946 

  5. 5. Younossi Z.M. Koenig A.B. Abdelatif D. Fazel Y. Henry L. Wymer M. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes Hepatology 2016 64 73 84 10.1002/hep.28431 26707365 

  6. 6. Yu M.W. Lin C.L. Liu C.J. Yang S.H. Tseng Y.L. Wu C.F. Influence of Metabolic Risk Factors on Risk of Hepatocellular Carcinoma and Liver-Related Death in Men With Chronic Hepatitis B: A Large Cohort Study Gastroenterology 2017 153 1006 1017 10.1053/j.gastro.2017.07.001 28711626 

  7. 7. Torres H.A. Shigle T.L. Hammoudi N. Link J.T. Samaniego F. Kaseb A. Mallet V. The oncologic burden of hepatitis C virus infection: A clinical perspective CA Cancer J. Clin. 2017 67 411 431 10.3322/caac.21403 28683174 

  8. 8. Nakagawa S. Wei L. Song W.M. Higashi T. Ghoshal S. Kim R.S. Bian C.B. Yamada S. Sun X. Venkatesh A. Molecular Liver Cancer Prevention in Cirrhosis by Organ Transcriptome Analysis and Lysophosphatidic Acid Pathway Inhibition Cancer Cell 2016 30 879 890 10.1016/j.ccell.2016.11.004 27960085 

  9. 9. Parikh N.D. Singal A.G. Hutton D.W. Cost effectiveness of regorafenib as second-line therapy for patients with advanced hepatocellular carcinoma Cancer 2017 123 3725 3731 10.1002/cncr.30863 28662266 

  10. 10. Goossens N. Sun X. Hoshida Y. Molecular classification of hepatocellular carcinoma: Potential therapeutic implications Hepat. Oncol. 2015 2 371 379 10.2217/hep.15.26 26617981 

  11. 11. Cao Z. Fan-Minogue H. Bellovin D.I. Yevtodiyenko A. Arzeno J. Yang Q. Gambhir S.S. Felsher D.W. MYC phosphorylation, activation, and tumorigenic potential in hepatocellular carcinoma are regulated by HMG-CoA reductase Cancer Res. 2011 71 2286 2297 10.1158/0008-5472.CAN-10-3367 21262914 

  12. 12. Yang P.M. Liu Y.L. Lin Y.C. Shun C.T. Wu M.S. Chen C.C. Inhibition of autophagy enhances anticancer effects of atorvastatin in digestive malignancies Cancer Res. 2010 70 7699 7709 10.1158/0008-5472.CAN-10-1626 20876807 

  13. 13. Sutter A.P. Maaser K. Hopfner M. Huether A. Schuppan D. Scherubl H. Cell cycle arrest and apoptosis induction in hepatocellular carcinoma cells by HMG-CoA reductase inhibitors. Synergistic antiproliferative action with ligands of the peripheral benzodiazepine receptor J. Hepatol. 2005 43 808 816 10.1016/j.jhep.2005.04.010 16083991 

  14. 14. Hoshida Y. Fuchs B.C. Tanabe K.K. Prevention of hepatocellular carcinoma: Potential targets, experimental models, and clinical challenges Curr. Cancer Drug Targets 2012 12 1129 1159 22873223 

  15. 15. Eddy S.R. Non-coding RNA genes and the modern RNA world Nat. Rev. Genet. 2001 2 919 929 10.1038/35103511 11733745 

  16. 16. Uszczynska-Ratajczak B. Lagarde J. Frankish A. Guigo R. Johnson R. Towards a complete map of the human long non-coding RNA transcriptome Nat. Rev. Genet. 2018 19 535 548 10.1038/s41576-018-0017-y 29795125 

  17. 17. Li W. Notani D. Rosenfeld M.G. Enhancers as non-coding RNA transcription units: Recent insights and future perspectives Nat. Rev. Genet. 2016 17 207 223 10.1038/nrg.2016.4 26948815 

  18. 18. Anastasiadou E. Jacob L.S. Slack F.J. Non-coding RNA networks in cancer Nat. Rev. Cancer 2018 18 5 18 10.1038/nrc.2017.99 29170536 

  19. 19. Slack F.J. Chinnaiyan A.M. The Role of Non-coding RNAs in Oncology Cell 2019 179 1033 1055 10.1016/j.cell.2019.10.017 31730848 

  20. 20. Wong C.M. Tsang F.H. Ng I.O. Non-coding RNAs in hepatocellular carcinoma: Molecular functions and pathological implications Nat. Rev. Gastroenterol. Hepatol. 2018 15 137 151 10.1038/nrgastro.2017.169 29317776 

  21. 21. Quinn J.J. Chang H.Y. Unique features of long non-coding RNA biogenesis and function Nat. Rev. Genet. 2016 17 47 62 10.1038/nrg.2015.10 26666209 

  22. 22. Yao R.-W. Wang Y. Chen L.-L. Cellular functions of long noncoding RNAs Nat. Cell Biol. 2019 21 542 551 10.1038/s41556-019-0311-8 31048766 

  23. 23. Wang X. Sun W. Shen W. Xia M. Chen C. Xiang D. Ning B. Cui X. Li H. Li X. Long non-coding RNA DILC regulates liver cancer stem cells via IL-6/STAT3 axis J. Hepatol. 2016 64 1283 1294 10.1016/j.jhep.2016.01.019 26812074 

  24. 24. Schmitt A.M. Chang H.Y. Long Noncoding RNAs in Cancer Pathways Cancer Cell 2016 29 452 463 10.1016/j.ccell.2016.03.010 27070700 

  25. 25. Li X. Yang L. Chen L.L. The Biogenesis, Functions, and Challenges of Circular RNAs Mol. Cell 2018 71 428 442 10.1016/j.molcel.2018.06.034 30057200 

  26. 26. Yu J. Xu Q.G. Wang Z.G. Yang Y. Zhang L. Ma J.Z. Sun S.H. Yang F. Zhou W.P. Circular RNA cSMARCA5 inhibits growth and metastasis in hepatocellular carcinoma J. Hepatol. 2018 68 1214 1227 10.1016/j.jhep.2018.01.012 29378234 

  27. 27. Zhang X. Wang S. Wang H. Cao J. Huang X. Chen Z. Xu P. Sun G. Xu J. Lv J. Circular RNA circNRIP1 acts as a microRNA-149-5p sponge to promote gastric cancer progression via the AKT1/mTOR pathway Mol. Cancer 2019 18 20 10.1186/s12943-018-0935-5 30717751 

  28. 28. Huang X. Toth K.F. Aravin A.A. piRNA Biogenesis in Drosophila melanogaster Trends Genet. 2017 33 882 894 10.1016/j.tig.2017.09.002 28964526 

  29. 29. Kim V.N. Han J. Siomi M.C. Biogenesis of small RNAs in animals Nat. Rev. Mol. Cell Biol. 2009 10 126 139 10.1038/nrm2632 19165215 

  30. 30. Ha M. Kim V.N. Regulation of microRNA biogenesis Nat. Rev. Mol. Cell Biol. 2014 15 509 524 10.1038/nrm3838 25027649 

  31. 31. Bartel D.P. MicroRNAs: Genomics, biogenesis, mechanism, and function Cell 2004 116 281 297 10.1016/S0092-8674(04)00045-5 14744438 

  32. 32. Jonas S. Izaurralde E. Towards a molecular understanding of microRNA-mediated gene silencing Nat. Rev. Genet. 2015 16 421 433 10.1038/nrg3965 26077373 

  33. 33. Hausser J. Zavolan M. Identification and consequences of miRNA-target interactions―Beyond repression of gene expression Nat. Rev. Genet. 2014 15 599 612 10.1038/nrg3765 25022902 

  34. 34. Bassett A.R. Azzam G. Wheatley L. Tibbit C. Rajakumar T. McGowan S. Stanger N. Ewels P.A. Taylor S. Ponting C.P. Understanding functional miRNA-target interactions in vivo by site-specific genome engineering Nat. Commun. 2014 5 4640 10.1038/ncomms5640 25135198 

  35. 35. Bracken C.P. Scott H.S. Goodall G.J. A network-biology perspective of microRNA function and dysfunction in cancer Nat. Rev. Genet. 2016 17 719 732 10.1038/nrg.2016.134 27795564 

  36. 36. Han T.S. Hur K. Xu G. Choi B. Okugawa Y. Toiyama Y. Oshima H. Oshima M. Lee H.J. Kim V.N. MicroRNA-29c mediates initiation of gastric carcinogenesis by directly targeting ITGB1 Gut 2015 64 203 214 10.1136/gutjnl-2013-306640 24870620 

  37. 37. Han T.S. Voon D.C. Oshima H. Nakayama M. Echizen K. Sakai E. Yong Z.W.E. Murakami K. Yu L. Minamoto T. Interleukin 1 Up-regulates MicroRNA 135b to Promote Inflammation-Associated Gastric Carcinogenesis in Mice Gastroenterology 2019 156 1140 1155 10.1053/j.gastro.2018.11.059 30508510 

  38. 38. Hwang J.S. Jeong E.J. Choi J. Lee Y.J. Jung E. Kim S.K. Min J.K. Han T.S. Kim J.S. MicroRNA-1258 Inhibits the Proliferation and Migration of Human Colorectal Cancer Cells through Suppressing CKS1B Expression Genes 2019 10 912 10.3390/genes10110912 

  39. 39. Law P.T. Qin H. Ching A.K. Lai K.P. Co N.N. He M. Lung R.W. Chan A.W. Chan T.F. Wong N. Deep sequencing of small RNA transcriptome reveals novel non-coding RNAs in hepatocellular carcinoma J. Hepatol. 2013 58 1165 1173 10.1016/j.jhep.2013.01.032 23376363 

  40. 40. Sandbothe M. Buurman R. Reich N. Greiwe L. Vajen B. Gurlevik E. Schaffer V. Eilers M. Kuhnel F. Vaquero A. The microRNA-449 family inhibits TGF-beta-mediated liver cancer cell migration by targeting SOX4 J. Hepatol. 2017 66 1012 1021 10.1016/j.jhep.2017.01.004 28088579 

  41. 41. Peng Y. Croce C.M. The role of MicroRNAs in human cancer Signal Transduct. Target. Ther. 2016 1 15004 10.1038/sigtrans.2015.4 29263891 

  42. 42. Jansson M.D. Lund A.H. MicroRNA and cancer Mol. Oncol. 2012 6 590 610 10.1016/j.molonc.2012.09.006 23102669 

  43. 43. Han T.S. Ban H.S. Hur K. Cho H.S. The Epigenetic Regulation of HCC Metastasis Int. J. Mol. Sci. 2018 19 3978 10.3390/ijms19123978 

  44. 44. Bae H.J. Jung K.H. Eun J.W. Shen Q. Kim H.S. Park S.J. Shin W.C. Yang H.D. Park W.S. Lee J.Y. MicroRNA-221 governs tumor suppressor HDAC6 to potentiate malignant progression of liver cancer J. Hepatol. 2015 63 408 419 10.1016/j.jhep.2015.03.019 25817558 

  45. 45. Liu S. Guo W. Shi J. Li N. Yu X. Xue J. Fu X. Chu K. Lu C. Zhao J. MicroRNA-135a contributes to the development of portal vein tumor thrombus by promoting metastasis in hepatocellular carcinoma J. Hepatol. 2012 56 389 396 10.1016/j.jhep.2011.08.008 21888875 

  46. 46. Rybak A. Fuchs H. Smirnova L. Brandt C. Pohl E.E. Nitsch R. Wulczyn F.G. A feedback loop comprising lin-28 and let-7 controls pre-let-7 maturation during neural stem-cell commitment Nat. Cell Biol. 2008 10 987 993 10.1038/ncb1759 18604195 

  47. 47. Sayed D. Rane S. Lypowy J. He M. Chen I.Y. Vashistha H. Yan L. Malhotra A. Vatner D. Abdellatif M. MicroRNA-21 targets Sprouty2 and promotes cellular outgrowths Mol. Biol. Cell 2008 19 3272 3282 10.1091/mbc.e08-02-0159 18508928 

  48. 48. Horie T. Ono K. Nishi H. Iwanaga Y. Nagao K. Kinoshita M. Kuwabara Y. Takanabe R. Hasegawa K. Kita T. MicroRNA-133 regulates the expression of GLUT4 by targeting KLF15 and is involved in metabolic control in cardiac myocytes Biochem. Biophys. Res. Commun. 2009 389 315 320 10.1016/j.bbrc.2009.08.136 19720047 

  49. 49. Franco-Zorrilla J.M. Valli A. Todesco M. Mateos I. Puga M.I. Rubio-Somoza I. Leyva A. Weigel D. Garcia J.A. Paz-Ares J. Target mimicry provides a new mechanism for regulation of microRNA activity Nat. Genet. 2007 39 1033 1037 10.1038/ng2079 17643101 

  50. 50. Chitwood D.H. Timmermans M.C. Target mimics modulate miRNAs Nat. Genet. 2007 39 935 936 10.1038/ng0807-935 17660806 

  51. 51. Ebert M.S. Sharp P.A. MicroRNA sponges: Progress and possibilities RNA 2010 16 2043 2050 10.1261/rna.2414110 20855538 

  52. 52. Salmena L. Poliseno L. Tay Y. Kats L. Pandolfi P.P. A ceRNA hypothesis: The Rosetta Stone of a hidden RNA language? Cell 2011 146 353 358 10.1016/j.cell.2011.07.014 21802130 

  53. 53. Zhao L. Han T. Li Y. Sun J. Zhang S. Liu Y. Shan B. Zheng D. Shi J. The lncRNA SNHG5/miR-32 axis regulates gastric cancer cell proliferation and migration by targeting KLF4 FASEB J. 2017 31 893 903 10.1096/fj.201600994R 27871067 

  54. 54. Zhong Y. Du Y. Yang X. Mo Y. Fan C. Xiong F. Ren D. Ye X. Li C. Wang Y. Circular RNAs function as ceRNAs to regulate and control human cancer progression Mol. Cancer 2018 17 79 10.1186/s12943-018-0827-8 29626935 

  55. 55. Huang W. Huang F. Lei Z. Luo H. LncRNA SNHG11 Promotes Proliferation, Migration, Apoptosis, and Autophagy by Regulating hsa-miR-184/AGO2 in HCC Onco Targets Ther. 2020 13 413 421 10.2147/OTT.S237161 32021286 

  56. 56. Deng L. Yang S.B. Xu F.F. Zhang J.H. Long noncoding RNA CCAT1 promotes hepatocellular carcinoma progression by functioning as let-7 sponge J. Exp. Clin. Cancer Res. 2015 34 18 10.1186/s13046-015-0136-7 25884472 

  57. 57. Li S. Peng F. Ning Y. Jiang P. Peng J. Ding X. Zhang J. Jiang T. Xiang S. SNHG16 as the miRNA let-7b-5p sponge facilitates the G2/M and epithelial-mesenchymal transition by regulating CDC25B and HMGA2 expression in hepatocellular carcinoma J. Cell. Biochem. 2020 121 2543 2558 10.1002/jcb.29477 31696971 

  58. 58. Huang Y. Xiang B. Liu Y. Wang Y. Kan H. LncRNA CDKN2B-AS1 promotes tumor growth and metastasis of human hepatocellular carcinoma by targeting let-7c-5p/NAP1L1 axis Cancer Lett. 2018 437 56 66 10.1016/j.canlet.2018.08.024 30165194 

  59. 59. Gong J. Wang J. Liu T. Hu J. Zheng J. lncRNA FEZF1AS1 contributes to cell proliferation, migration and invasion by sponging miR4443 in hepatocellular carcinoma Mol. Med. Rep. 2018 18 5614 5620 10.3892/mmr.2018.9585 30365146 

  60. 60. Wei L.Q. Li L. Lu C. Liu J. Chen Y. Wu H. Involvement of H19/miR-326 axis in hepatocellular carcinoma development through modulating TWIST1 J. Cell. Physiol. 2019 234 5153 5162 10.1002/jcp.27319 30362512 

  61. 61. Pan Y. Tong S. Cui R. Fan J. Liu C. Lin Y. Tang J. Xie H. Lin P. Zheng T. Long Non-Coding MALAT1 Functions as a Competing Endogenous RNA to Regulate Vimentin Expression by Sponging miR-30a-5p in Hepatocellular Carcinoma Cell. Physiol. Biochem. 2018 50 108 120 10.1159/000493962 30278452 

  62. 62. Li C. Miao R. Liu S. Wan Y. Zhang S. Deng Y. Bi J. Qu K. Zhang J. Liu C. Down-regulation of miR-146b-5p by long noncoding RNA MALAT1 in hepatocellular carcinoma promotes cancer growth and metastasis Oncotarget 2017 8 28683 28695 10.18632/oncotarget.15640 28404923 

  63. 63. Chang Y. Zhang J. Zhou C. Qiu G. Wang G. Wang S. Chang X. Li X. Fan L. Long non-coding RNA FOXD2-AS1 plays an oncogenic role in hepatocellular carcinoma by targeting miR206 Oncol. Rep. 2018 40 3625 3634 10.3892/or.2018.6752 30272362 

  64. 64. Hu M. Han Y. Zhang Y. Zhou Y. Ye L. lncRNA TINCR sponges miR-214-5p to upregulate ROCK1 in hepatocellular carcinoma BMC Med. Genet. 2020 21 2 10.1186/s12881-019-0940-6 31900116 

  65. 65. Dai W. Dai J.L. Tang M.H. Ye M.S. Fang S. lncRNA-SNHG15 accelerates the development of hepatocellular carcinoma by targeting miR-490-3p/ histone deacetylase 2 axis World J. Gastroenterol. 2019 25 5789 5799 10.3748/wjg.v25.i38.5789 31636472 

  66. 66. Dong J. Teng F. Guo W. Yang J. Ding G. Fu Z. lncRNA SNHG8 Promotes the Tumorigenesis and Metastasis by Sponging miR-149-5p and Predicts Tumor Recurrence in Hepatocellular Carcinoma Cell. Physiol. Biochem. 2018 51 2262 2274 10.1159/000495871 30537734 

  67. 67. Zhang K. Zhao Z. Yu J. Chen W. Xu Q. Chen L. LncRNA FLVCR1-AS1 acts as miR-513c sponge to modulate cancer cell proliferation, migration, and invasion in hepatocellular carcinoma J. Cell. Biochem. 2018 119 6045 6056 10.1002/jcb.26802 29574975 

  68. 68. Li C. Lu L. Feng B. Zhang K. Han S. Hou D. Chen L. Chu X. Wang R. The lincRNA-ROR/miR-145 axis promotes invasion and metastasis in hepatocellular carcinoma via induction of epithelial-mesenchymal transition by targeting ZEB2 Sci. Rep. 2017 7 4637 10.1038/s41598-017-04113-w 28680141 

  69. 69. Tu J. Zhao Z. Xu M. Chen M. Weng Q. Ji J. LINC00460 promotes hepatocellular carcinoma development through sponging miR-485-5p to up-regulate PAK1 Biomed. Pharmacother. 2019 118 109213 10.1016/j.biopha.2019.109213 31376654 

  70. 70. Gao J. Yin X. Yu X. Dai C. Zhou F. Long noncoding RNA LINC00488 functions as a ceRNA to regulate hepatocellular carcinoma cell growth and angiogenesis through miR-330-5 Dig. Liver Dis. 2019 51 1050 1059 10.1016/j.dld.2019.03.012 31005556 

  71. 71. Wang Y. Sun L. Wang L. Liu Z. Li Q. Yao B. Wang C. Chen T. Tu K. Liu Q. Long non-coding RNA DSCR8 acts as a molecular sponge for miR-485-5p to activate Wnt/beta-catenin signal pathway in hepatocellular carcinoma Cell Death Dis. 2018 9 851 10.1038/s41419-018-0937-7 30154476 

  72. 72. Bao J. Chen X. Hou Y. Kang G. Li Q. Xu Y. LncRNA DBH-AS1 facilitates the tumorigenesis of hepatocellular carcinoma by targeting miR-138 via FAK/Src/ERK pathway Biomed. Pharmacother. 2018 107 824 833 10.1016/j.biopha.2018.08.079 30142544 

  73. 73. Lv J. Kong Y. Gao Z. Liu Y. Zhu P. Yu Z. LncRNA TUG1 interacting with miR-144 contributes to proliferation, migration and tumorigenesis through activating the JAK2/STAT3 pathway in hepatocellular carcinoma Int. J. Biochem. Cell Biol. 2018 101 19 28 10.1016/j.biocel.2018.05.010 29791864 

  74. 74. Lan T. Ma W. Hong Z. Wu L. Chen X. Yuan Y. Long non-coding RNA small nucleolar RNA host gene 12 (SNHG12) promotes tumorigenesis and metastasis by targeting miR-199a/b-5p in hepatocellular carcinoma J. Exp. Clin. Cancer Res. 2017 36 11 10.1186/s13046-016-0486-9 28073380 

  75. 75. Cao C. Zhang T. Zhang D. Xie L. Zou X. Lei L. Wu D. Liu L. The long non-coding RNA, SNHG6-003, functions as a competing endogenous RNA to promote the progression of hepatocellular carcinoma Oncogene 2017 36 1112 1122 10.1038/onc.2016.278 27530352 

  76. 76. Wang F. Ying H.Q. He B.S. Pan Y.Q. Deng Q.W. Sun H.L. Chen J. Liu X. Wang S.K. Upregulated lncRNA-UCA1 contributes to progression of hepatocellular carcinoma through inhibition of miR-216b and activation of FGFR1/ERK signaling pathway Oncotarget 2015 6 7899 7917 10.18632/oncotarget.3219 25760077 

  77. 77. Li X. Zhou Y. Yang L. Ma Y. Peng X. Yang S. Li H. Liu J. LncRNA NEAT1 promotes autophagy via regulating miR-204/ATG3 and enhanced cell resistance to sorafenib in hepatocellular carcinoma J. Cell. Physiol. 2020 235 3402 3413 10.1002/jcp.29230 31549407 

  78. 78. Guo J. Ma Y. Peng X. Jin H. Liu J. LncRNA CCAT1 promotes autophagy via regulating ATG7 by sponging miR-181 in hepatocellular carcinoma J. Cell. Biochem. 2019 120 17975 17983 10.1002/jcb.29064 31218739 

  79. 79. Yang L. Peng X. Jin H. Liu J. Long non-coding RNA PVT1 promotes autophagy as ceRNA to target ATG3 by sponging microRNA-365 in hepatocellular carcinoma Gene 2019 697 94 102 10.1016/j.gene.2019.02.036 30794914 

  80. 80. Zhao L. Hu K. Cao J. Wang P. Li J. Zeng K. He X. Tu P.F. Tong T. Han L. lncRNA miat functions as a ceRNA to upregulate sirt1 by sponging miR-22-3p in HCC cellular senescence Aging 2019 11 7098 7122 10.18632/aging.102240 31503007 

  81. 81. Xiang Y. Huang Y. Sun H. Pan Y. Wu M. Zhang J. Deregulation of miR-520d-3p promotes hepatocellular carcinoma development via lncRNA MIAT regulation and EPHA2 signaling activation Biomed. Pharmacother. 2019 109 1630 1639 10.1016/j.biopha.2018.11.014 30551417 

  82. 82. Wang C. Ke S. Li M. Lin C. Liu X. Pan Q. Downregulation of LncRNA GAS5 promotes liver cancer proliferation and drug resistance by decreasing PTEN expression Mol. Genet. Genom. 2020 295 251 260 10.1007/s00438-019-01620-5 31705194 

  83. 83. Xu F. Zha G. Wu Y. Cai W. Ao J. Overexpressing lncRNA SNHG16 inhibited HCC proliferation and chemoresistance by functionally sponging hsa-miR-93 Onco Targets Ther. 2018 11 8855 8863 10.2147/OTT.S182005 30573973 

  84. 84. Zhang Y. Zhu Z. Huang S. Zhao Q. Huang C. Tang Y. Sun C. Zhang Z. Wang L. Chen H. lncRNA XIST regulates proliferation and migration of hepatocellular carcinoma cells by acting as miR-497-5p molecular sponge and targeting PDCD4 Cancer Cell. Int. 2019 19 198 10.1186/s12935-019-0909-8 31384173 

  85. 85. Wang Y.G. Wang T. Shi M. Zhai B. Long noncoding RNA EPB41L4A-AS2 inhibits hepatocellular carcinoma development by sponging miR-301a-5p and targeting FOXL1 J. Exp. Clin. Cancer Res. 2019 38 153 10.1186/s13046-019-1128-9 30971290 

  86. 86. Wang Y.G. Liu J. Shi M. Chen F.X. LncRNA DGCR5 represses the development of hepatocellular carcinoma by targeting the miR-346/KLF14 axis J. Cell. Physiol. 2018 234 572 580 10.1002/jcp.26779 30216442 

  87. 87. Yan S. Tang Z. Chen K. Liu Y. Yu G. Chen Q. Dang H. Chen F. Ling J. Zhu L. Long noncoding RNA MIR31HG inhibits hepatocellular carcinoma proliferation and metastasis by sponging microRNA-575 to modulate ST7L expression J. Exp. Clin. Cancer Res. 2018 37 214 10.1186/s13046-018-0853-9 30176933 

  88. 88. Hu B. Cai H. Zheng R. Yang S. Zhou Z. Tu J. Long non-coding RNA 657 suppresses hepatocellular carcinoma cell growth by acting as a molecular sponge of miR-106a-5p to regulate PTEN expression Int. J. Biochem. Cell Biol. 2017 92 34 42 10.1016/j.biocel.2017.09.008 28919047 

  89. 89. Wang Y. Liu Z. Yao B. Dou C. Xu M. Xue Y. Ding L. Jia Y. Zhang H. Li Q. Long non-coding RNA TUSC7 acts a molecular sponge for miR-10a and suppresses EMT in hepatocellular carcinoma Tumor Biol. 2016 37 11429 11441 10.1007/s13277-016-4892-6 

  90. 90. Li Y. Shi H. Yuan J. Qiao L. Dong L. Wang Y. Downregulation of circular RNA circPVT1 restricts cell growth of hepatocellular carcinoma through downregulation of Sirtuin 7 via microRNA-3666 Clin. Exp. Pharmacol. Physiol. 2020 10.1111/1440-1681.13273 

  91. 91. Chen J. Li Y. Zheng Q. Bao C. He J. Chen B. Lyu D. Zheng B. Xu Y. Long Z. Circular RNA profile identifies circPVT1 as a proliferative factor and prognostic marker in gastric cancer Cancer Lett. 2017 388 208 219 10.1016/j.canlet.2016.12.006 27986464 

  92. 92. Wang Z. Su M. Xiang B. Zhao K. Qin B. Circular RNA PVT1 promotes metastasis via miR-145 sponging in CRC Biochem. Biophys. Res. Commun. 2019 512 716 722 10.1016/j.bbrc.2019.03.121 30922567 

  93. 93. Qin S. Zhao Y. Lim G. Lin H. Zhang X. Zhang X. Circular RNA PVT1 acts as a competing endogenous RNA for miR-497 in promoting non-small cell lung cancer progression Biomed. Pharmacother. 2019 111 244 250 10.1016/j.biopha.2018.12.007 30590312 

  94. 94. Xiao Y. Liu G. Sun Y. Gao Y. Ouyang X. Chang C. Gong L. Yeh S. Targeting the estrogen receptor alpha (ERalpha)-mediated circ-SMG1.72/miR-141-3p/Gelsolin signaling to better suppress the HCC cell invasion Oncogene 2020 39 2493 2508 10.1038/s41388-019-1150-6 31996784 

  95. 95. Huang X.Y. Huang Z.L. Xu Y.H. Zheng Q. Chen Z. Song W. Zhou J. Tang Z.Y. Huang X.Y. Comprehensive circular RNA profiling reveals the regulatory role of the circRNA-100338/miR-141-3p pathway in hepatitis B-related hepatocellular carcinoma Sci. Rep. 2017 7 5428 10.1038/s41598-017-05432-8 28710406 

  96. 96. Wu J. Liu S. Xiang Y. Qu X. Xie Y. Zhang X. Bioinformatic Analysis of Circular RNA-Associated ceRNA Network Associated with Hepatocellular Carcinoma BioMed Res. Int. 2019 2019 8308694 10.1155/2019/8308694 31886256 

  97. 97. Wei Y. Chen X. Liang C. Ling Y. Yang X. Ye X. Zhang H. Yang P. Cui X. Ren Y. A Noncoding Regulatory RNAs Network Driven by Circ-CDYL Acts Specifically in the Early Stages Hepatocellular Carcinoma Hepatology 2020 71 130 147 10.1002/hep.30795 31148183 

  98. 98. Qi S.X. Sun H. Liu H. Yu J. Jiang Z.Y. Yan P. Role and mechanism of circ-PRKCI in hepatocellular carcinoma World J. Gastroenterol. 2019 25 1964 1974 10.3748/wjg.v25.i16.1964 31086464 

  99. 99. Xie B. Zhao Z. Liu Q. Wang X. Ma Z. Li H. CircRNA has_circ_0078710 acts as the sponge of microRNA-31 involved in hepatocellular carcinoma progression Gene 2019 683 253 261 10.1016/j.gene.2018.10.043 30342168 

  100. 100. Liu H. Xue L. Song C. Liu F. Jiang T. Yang X. Overexpression of circular RNA circ_001569 indicates poor prognosis in hepatocellular carcinoma and promotes cell growth and metastasis by sponging miR-411-5p and miR-432-5p Biochem. Biophys. Res. Commun. 2018 503 2659 2665 10.1016/j.bbrc.2018.08.020 30086881 

  101. 101. Li M.F. Li Y.H. He Y.H. Wang Q. Zhang Y. Li X.F. Meng X.M. Huang C. Li J. Emerging roles of hsa_circ_0005075 targeting miR-431 in the progress of HCC Biomed. Pharmacother. 2018 99 848 858 10.1016/j.biopha.2018.01.150 29710484 

  102. 102. Bai N. Peng E. Qiu X. Lyu N. Zhang Z. Tao Y. Li X. Wang Z. circFBLIM1 act as a ceRNA to promote hepatocellular cancer progression by sponging miR-346 J. Exp. Clin. Cancer Res. 2018 37 172 10.1186/s13046-018-0838-8 30053867 

  103. 103. Chen G. Shi Y. Liu M. Sun J. circHIPK3 regulates cell proliferation and migration by sponging miR-124 and regulating AQP3 expression in hepatocellular carcinoma Cell Death Dis. 2018 9 175 10.1038/s41419-017-0204-3 29415990 

  104. 104. Tian F. Yu C. Wu M. Wu X. Wan L. Zhu X. MicroRNA-191 promotes hepatocellular carcinoma cell proliferation by has_circ_0000204/miR-191/KLF6 axis Cell Prolif. 2019 52 e12635 10.1111/cpr.12635 31334580 

  105. 105. Wang Z. Zhao Y. Wang Y. Jin C. Circular RNA circHIAT1 inhibits cell growth in hepatocellular carcinoma by regulating miR-3171/PTEN axis Biomed. Pharmacother. 2019 116 108932 10.1016/j.biopha.2019.108932 31108351 

  106. 106. Xu L. Feng X. Hao X. Wang P. Zhang Y. Zheng X. Li L. Ren S. Zhang M. Xu M. CircSETD3 (Hsa_circ_0000567) acts as a sponge for microRNA-421 inhibiting hepatocellular carcinoma growth J. Exp. Clin. Cancer Res. 2019 38 98 10.1186/s13046-019-1041-2 30795787 

  107. 107. Qiu L. Huang Y. Li Z. Dong X. Chen G. Xu H. Zeng Y. Cai Z. Liu X. Liu J. Circular RNA profiling identifies circADAMTS13 as a miR-484 sponge which suppresses cell proliferation in hepatocellular carcinoma Mol. Oncol. 2019 13 441 455 10.1002/1878-0261.12424 30537115 

  108. 108. Han D. Li J. Wang H. Su X. Hou J. Gu Y. Qian C. Lin Y. Liu X. Huang M. Circular RNA circMTO1 acts as the sponge of microRNA-9 to suppress hepatocellular carcinoma progression Hepatology 2017 66 1151 1164 10.1002/hep.29270 28520103 

  109. 109. Fu L. Chen Q. Yao T. Li T. Ying S. Hu Y. Guo J. Hsa_circ_0005986 inhibits carcinogenesis by acting as a miR-129-5p sponge and is used as a novel biomarker for hepatocellular carcinoma Oncotarget 2017 8 43878 43888 10.18632/oncotarget.16709 28410211 

  110. 110. Chen S. Zhang Y. Wu X. Zhang C. Li G. Diagnostic Value of lncRNAs as Biomarker in Hepatocellular Carcinoma: An Updated Meta-Analysis Can. J. Gastroenterol. Hepatol. 2018 2018 8410195 10.1155/2018/8410195 30410873 

  111. 111. Li G. Shi H. Wang X. Wang B. Qu Q. Geng H. Sun H. Identification of diagnostic long noncoding RNA biomarkers in patients with hepatocellular carcinoma Mol. Med. Rep. 2019 20 1121 1130 10.3892/mmr.2019.10307 31173205 

  112. 112. Chen F. Li Y. Li M. Wang L. Long noncoding RNA GAS5 inhibits metastasis by targeting miR-182/ANGPTL1 in hepatocellular carcinoma Am. J. Cancer Res. 2019 9 108 121 30755815 

  113. 113. Han M.H. Lee J.H. Kim G. Lee E. Lee Y.R. Jang S.Y. Lee H.W. Chun J.M. Han Y.S. Yoon J.S. Expression of the Long Noncoding RNA GAS5 Correlates with Liver Fibrosis in Patients with Nonalcoholic Fatty Liver Disease Genes 2020 11 545 10.3390/genes11050545 32413995 

  114. 114. Hu L. Ye H. Huang G. Luo F. Liu Y. Liu Y. Yang X. Shen J. Liu Q. Zhang J. Long noncoding RNA GAS5 suppresses the migration and invasion of hepatocellular carcinoma cells via miR-21 Tumour Biol. 2016 37 2691 2702 10.1007/s13277-015-4111-x 26404135 

  115. 115. Tu Z.Q. Li R.J. Mei J.Z. Li X.H. Down-regulation of long non-coding RNA GAS5 is associated with the prognosis of hepatocellular carcinoma Int. J. Clin. Exp. Pathol. 2014 7 4303 4309 25120813 

  116. 116. Wang J. Liu X. Wu H. Ni P. Gu Z. Qiao Y. Chen N. Sun F. Fan Q. CREB up-regulates long non-coding RNA, HULC expression through interaction with microRNA-372 in liver cancer Nucleic Acids Res. 2010 38 5366 5383 10.1093/nar/gkq285 20423907 

  117. 117. Wang Y. Chen F. Zhao M. Yang Z. Li J. Zhang S. Zhang W. Ye L. Zhang X. The long noncoding RNA HULC promotes liver cancer by increasing the expression of the HMGA2 oncogene via sequestration of the microRNA-186 J. Biol. Chem. 2017 292 15395 15407 10.1074/jbc.M117.783738 28765279 

  118. 118. Li J. Wang X. Tang J. Jiang R. Zhang W. Ji J. Sun B. HULC and Linc00152 Act as Novel Biomarkers in Predicting Diagnosis of Hepatocellular Carcinoma Cell. Physiol. Biochem. 2015 37 687 696 10.1159/000430387 26356260 

  119. 119. Konishi H. Ichikawa D. Yamamoto Y. Arita T. Shoda K. Hiramoto H. Hamada J. Itoh H. Fujita Y. Komatsu S. Plasma level of metastasis-associated lung adenocarcinoma transcript 1 is associated with liver damage and predicts development of hepatocellular carcinoma Cancer Sci. 2016 107 149 154 10.1111/cas.12854 26614531 

  120. 120. Zheng Z.K. Pang C. Yang Y. Duan Q. Zhang J. Liu W.C. Serum long noncoding RNA urothelial carcinoma-associated 1: A novel biomarker for diagnosis and prognosis of hepatocellular carcinoma J. Int. Med. Res. 2018 46 348 356 10.1177/0300060517726441 28856933 

  121. 121. Roberts L.R. Current Status of the GALAD and BALAD Biomarker Models for Hepatocellular Carcinoma Gastroenterol. Hepatol. 2019 15 672 675 

  122. 122. Best J. Bechmann L.P. Sowa J.P. Sydor S. Dechene A. Pflanz K. Bedreli S. Schotten C. Geier A. Berg T. GALAD Score Detects Early Hepatocellular Carcinoma in an International Cohort of Patients With Nonalcoholic Steatohepatitis Clin. Gastroenterol. Hepatol. 2020 18 728 735 10.1016/j.cgh.2019.11.012 31712073 

  123. 123. Shang X. Li G. Liu H. Li T. Liu J. Zhao Q. Wang C. Comprehensive Circular RNA Profiling Reveals That hsa_circ_0005075, a New Circular RNA Biomarker, Is Involved in Hepatocellular Crcinoma Development Medicine 2016 95 e3811 10.1097/MD.0000000000003811 27258521 

  124. 124. Jin Y.D. Ren Y.R. Gao Y.X. Zhang L. Ding Z. Hsa_circ_0005075 predicts a poor prognosis and acts as an oncogene in colorectal cancer via activating Wnt/beta-catenin pathway Eur. Rev. Med. Pharmacol. Sci. 2019 23 3311 3319 10.26355/eurrev_201904_17693 31081084 

  125. 125. Chen D. Zhang C. Lin J. Song X. Wang H. Screening differential circular RNA expression profiles reveal that hsa_circ_0128298 is a biomarker in the diagnosis and prognosis of hepatocellular carcinoma Cancer Manag. Res. 2018 10 1275 1283 10.2147/CMAR.S166740 29849467 

  126. 126. Fu L. Yao T. Chen Q. Mo X. Hu Y. Guo J. Screening differential circular RNA expression profiles reveals hsa_circ_0004018 is associated with hepatocellular carcinoma Oncotarget 2017 8 58405 58416 10.18632/oncotarget.16881 28938566 

  127. 127. Wang M. Gu B. Yao G. Li P. Wang K. Circular RNA Expression Profiles and the Pro-tumorigenic Function of CircRNA_10156 in Hepatitis B Virus-Related Liver Cancer Int. J. Med. Sci. 2020 17 1351 1365 10.7150/ijms.45637 32624692 

  128. 128. Memczak S. Papavasileiou P. Peters O. Rajewsky N. Identification and Characterization of Circular RNAs As a New Class of Putative Biomarkers in Human Blood PLoS ONE 2015 10 e0141214 10.1371/journal.pone.0141214 26485708 

  129. 129. Mehinovic L. Islamagic E. Husic-Selimovic A. Kurtovic-Kozaric A. Vukobrat-Bijedic Z. Suljevic D. Evaluation of Diagnostic Efficiency of Alpha-Fetoprotein in Patients with Liver Cirrhosis and Hepatocellular Carcinoma: Single-Center Experience Open Access Maced. J. Med. Sci. 2018 6 1668 1673 10.3889/oamjms.2018.344 30337985 

  130. 130. Li Y. Zheng Q. Bao C. Li S. Guo W. Zhao J. Chen D. Gu J. He X. Huang S. Circular RNA is enriched and stable in exosomes: A promising biomarker for cancer diagnosis Cell Res. 2015 25 981 984 10.1038/cr.2015.82 26138677 

  131. 131. Dai X. Chen C. Yang Q. Xue J. Chen X. Sun B. Luo F. Liu X. Xiao T. Xu H. Exosomal circRNA_100284 from arsenite-transformed cells, via microRNA-217 regulation of EZH2, is involved in the malignant transformation of human hepatic cells by accelerating the cell cycle and promoting cell proliferation Cell Death Dis. 2018 9 454 10.1038/s41419-018-0485-1 29674685 

  132. 132. Wang G. Liu W. Zou Y. Wang G. Deng Y. Luo J. Zhang Y. Li H. Zhang Q. Yang Y. Three isoforms of exosomal circPTGR1 promote hepatocellular carcinoma metastasis via the miR449a-MET pathway EBioMedicine 2019 40 432 445 10.1016/j.ebiom.2018.12.062 30630697 

  133. 133. Zhang H. Deng T. Ge S. Liu Y. Bai M. Zhu K. Fan Q. Li J. Ning T. Tian F. Exosome circRNA secreted from adipocytes promotes the growth of hepatocellular carcinoma by targeting deubiquitination-related USP7 Oncogene 2019 38 2844 2859 10.1038/s41388-018-0619-z 30546088 

  134. 134. Tang W. Chen Z. Zhang W. Cheng Y. Zhang B. Wu F. Wang Q. Wang S. Rong D. Reiter F.P. The mechanisms of sorafenib resistance in hepatocellular carcinoma: Theoretical basis and therapeutic aspects Signal Transduct. Target. Ther. 2020 5 87 10.1038/s41392-020-0187-x 32532960 

  135. 135. Jin W. Chen L. Cai X. Zhang Y. Zhang J. Ma D. Cai X. Fu T. Yu Z. Yu F. Long non-coding RNA TUC338 is functionally involved in sorafenib-sensitized hepatocarcinoma cells by targeting RASAL1 Oncol. Rep. 2017 37 273 280 10.3892/or.2016.5248 27878301 

  136. 136. Takahashi K. Yan I.K. Wood J. Haga H. Patel T. Involvement of extracellular vesicle long noncoding RNA (linc-VLDLR) in tumor cell responses to chemotherapy Mol. Cancer Res. 2014 12 1377 1387 10.1158/1541-7786.MCR-13-0636 24874432 

  137. 137. Wu M.Y. Tang Y.P. Liu J.J. Liang R. Luo X.L. Global transcriptomic study of circRNAs expression profile in sorafenib resistant hepatocellular carcinoma cells J. Cancer 2020 11 2993 3001 10.7150/jca.39854 32226514 

  138. 138. Gao Y. Wang J. Zhao F. CIRI: An efficient and unbiased algorithm for de novo circular RNA identification Genome Biol. 2015 16 4 10.1186/s13059-014-0571-3 25583365 

  139. 139. Gao Y. Zhang J. Zhao F. Circular RNA identification based on multiple seed matching Brief. Bioinform. 2018 19 803 810 10.1093/bib/bbx014 28334140 

LOADING...

활용도 분석정보

상세보기
다운로드
내보내기

활용도 Top5 논문

해당 논문의 주제분야에서 활용도가 높은 상위 5개 콘텐츠를 보여줍니다.
더보기 버튼을 클릭하시면 더 많은 관련자료를 살펴볼 수 있습니다.

관련 콘텐츠

오픈액세스(OA) 유형

GOLD

오픈액세스 학술지에 출판된 논문

유발과제정보 저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로